These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by cysteine endopeptidase inactivators. Buttle DJ; Saklatvala J; Barrett AJ Agents Actions Suppl; 1993; 39():161-5. PubMed ID: 8456627 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Buttle DJ; Handley CJ; Ilic MZ; Saklatvala J; Murata M; Barrett AJ Arthritis Rheum; 1993 Dec; 36(12):1709-17. PubMed ID: 8250991 [TBL] [Abstract][Full Text] [Related]
5. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown. Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524 [TBL] [Abstract][Full Text] [Related]
6. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture. Arner EC; Pratta MA Arthritis Rheum; 1989 Mar; 32(3):288-97. PubMed ID: 2784682 [TBL] [Abstract][Full Text] [Related]
7. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Sztrolovics R; White RJ; Poole AR; Mort JS; Roughley PJ Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):571-7. PubMed ID: 10215595 [TBL] [Abstract][Full Text] [Related]
8. Site specific inhibition of cartilage proteoglycan synthesis in the murine knee joint. Differences between 3 metabolic stimuli. van Osch GJ; van der Kraan PM; van den Berg WB J Rheumatol; 1994 Jun; 21(6):1107-12. PubMed ID: 7932423 [TBL] [Abstract][Full Text] [Related]
9. A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokines. Bryson H; Bunning RA; Feltell R; Kam CM; Kerrigan J; Powers JC; Buttle DJ Arch Biochem Biophys; 1998 Jul; 355(1):15-25. PubMed ID: 9647662 [TBL] [Abstract][Full Text] [Related]
11. Evidence that the inhibition of cartilage proteoglycan breakdown by mannosamine is not mediated via inhibition of glycosylphosphatidylinositol anchor formation. Bryson H; Buttle DJ; Kozaci LD; Johnatty RN; Bunning RA Biochem J; 2000 Feb; 345 Pt 3(Pt 3):495-501. PubMed ID: 10642507 [TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin-1-beta and tumor necrosis factor-alpha on cartilage proteoglycan metabolism in vitro. Pratta MA; Di Meo TM; Ruhl DM; Arner EC Agents Actions; 1989 Jun; 27(3-4):250-3. PubMed ID: 2801305 [TBL] [Abstract][Full Text] [Related]
13. Effect of ebselen on IL-1-induced alterations in cartilage metabolism. Pratta MA; Ackerman NR; Arner EC Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of bone resorption by selective inactivators of cysteine proteinases. Hill PA; Buttle DJ; Jones SJ; Boyde A; Murata M; Reynolds JJ; Meikle MC J Cell Biochem; 1994 Sep; 56(1):118-30. PubMed ID: 7806585 [TBL] [Abstract][Full Text] [Related]
17. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures. Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787 [TBL] [Abstract][Full Text] [Related]
18. The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants. Nietfeld JJ; Wilbrink B; Den Otter W; Huber J; Huber-Bruning O J Rheumatol; 1990 Jun; 17(6):818-26. PubMed ID: 2388205 [TBL] [Abstract][Full Text] [Related]
19. Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type II collagen degradation in vitro. Adcocks C; Collin P; Buttle DJ J Nutr; 2002 Mar; 132(3):341-6. PubMed ID: 11880552 [TBL] [Abstract][Full Text] [Related]
20. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities. Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]